Enhanced Antisense Inhibition of Human Immunodeficiency Virus Type 1 in Cell Cultures by DLS Delivery System
- 28 August 1997
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 237 (3) , 566-571
- https://doi.org/10.1006/bbrc.1997.7191
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Inhibition of Influenza Virus RNA Polymerase and Nucleoprotein Genes Expression by Unmodified, Phosphorothioated, and Liposomally Encapsulated OligonucleotidesBiochemical and Biophysical Research Communications, 1996
- Antisense oligonucleotide therapeutics: drug delivery and targetingAdvanced Drug Delivery Reviews, 1996
- Gene inhibition using antisense oligodeoxynucleotidesNature, 1994
- Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?Science, 1993
- Overcoming Multidrug Resistance in Human Tumor Cells Using Free and Liposomally Encapsulated Antisense OligodeoxynucleotidesBiochemical and Biophysical Research Communications, 1993
- Use of Cationic Lipids to Enhance the Biological Activity of Antisense OligonucleotidesJournal of Liposome Research, 1993
- Liposomal Delivery of Antisense Oligodeoxynucleotides.Annals of the New York Academy of Sciences, 1992
- Oligonucleotides encapsulated in pH sensitive liposomes are efficient toward Friend retrovirusBiochemical and Biophysical Research Communications, 1992
- Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activityNucleic Acids Research, 1992
- Antibody-targeted liposomes containing oligodeoxyribonucleotides complementary to viral RNA selectively inhibit viral replication.Proceedings of the National Academy of Sciences, 1990